Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last $133.05 USD
Change Today -1.72 / -1.28%
Volume 1.6M
CI On Other Exchanges
New York
As of 4:15 PM 02/5/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

900 Cottage Grove Road

Bloomfield, CT 06002

United States

Phone: 860-226-6000

Fax: 860-226-6741

porate-owned Life Insurance (COLI) The principal products of the COLI business are permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for the purpose of financing employer-paid future benefit obligations. Permanent life insurance provides coverage that, when adequately funded, does not expire after a term of years. The contracts are primarily non-participating universal life policies. Individual Life Insurance and Annuity and Retirement Benefits Businesses This business includes the sale of the individual life insurance and annuity business, and the sale of the retirement benefits business. Run-off Settlement Annuity Business The company’s settlement annuity business is a closed, run-off block of single premium annuity contracts. These contracts are primarily liability settlements with approximately 23% of the liabilities associated with payments that are guaranteed and not contingent on survivorship. For contracts that involve non-guaranteed payments, such payments are contingent on the survival of one or more parties involved in the settlement. Strategy The company’s strategy is to ‘Go Deep’, ‘Go Global’, and ‘Go Individual’ with a differentiated set of medical, dental, disability, life and accident insurance and related products and services offered by its subsidiaries. Regulation The expansion of the company’s operations into foreign countries increases its exposure to certain U.S. laws, such as the Foreign Corrupt Practices Act of 1977. The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act mandate changes affecting insured and self-insured health benefit plans that impact the company’s business model, including its relationship with current and future customers, producers and health care providers, products, services, processes and technology. Certain of the company’s subsidiaries are pharmacies that dispense prescription drugs to participants of benefit plans administered or insured by its HMO and insurance company subsidiaries. These pharmacy-subsidiaries are subject to state licensing requirements and regulation, as well as U.S. Drug Enforcement Agency registration requirements. The company’s operations in countries outside the United States are subject to local regulations in the locations in which its subsidiaries conduct business; in some cases, are subject to regulations in the locations of customers; and in all cases, are subject to the Foreign Corrupt Practices Act of 1977. The company’s domestic subsidiaries sell majority of their products and services to sponsors of employee benefit plans that are governed by the Employee Retirement Income Security Act of 1974, as amended. The company’s domestic subsidiaries are subject to requirements imposed by the Employee Retirement Income Security Act of 1974, as amended affecting claim payment and appeals procedures for individual health insurance and insured and self-insured group health plans and for the insured dental, disability, life and accident plans that the company administers. Several of the company’s subsidiaries engage in businesses that are subject to federal Medicare regulations, such as those offering individual and group Medicare Advantage (HMO) coverage; those offering Medicare Pharmacy (Part D) products that are subject to federal Medicare regulations; and billing of Medicare Part B claims on behalf of providers with whom the company has contractual management agreements. The company is also subject to regulation by the Office of Foreign Assets Control of the Department of the Treasury, which administers and enforces economic and trade sanctions based on the U.S. foreign policy and national security goals against targeted foreign countries and regimes. Certain of the company’s products are subject to Department of the Treasury anti-money laundering regulations under the Bank Secrecy Act. History Cigna Corporation was founded in 1792. The company was incorporated in the state of Delaware in 1981.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CI:US $133.05 USD -1.72

CI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $99.22 USD -2.89
Capital One Financial Corp $63.36 USD -0.37
Humana Inc $164.78 USD -3.87
Prudential Financial Inc $65.35 USD -1.63
Allstate Corp/The $63.37 USD +1.32
View Industry Companies

Industry Analysis


Industry Average

Valuation CI Industry Range
Price/Earnings 16.2x
Price/Sales 0.9x
Price/Book 2.9x
Price/Cash Flow 16.2x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CIGNA CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at